The structural comparison
| Dimension | Research supply | Prescribed telehealth |
|---|---|---|
| What you sell | Product to research buyers | A clinical service to patients |
| Who is between you and the end user | Nobody | A prescriber and a pharmacy |
| Claim vocabulary | None permitted about human use | Clinical claims permitted within the prescriber relationship |
| Fulfillment | Your warehouse or your supplier’s | 503A or 503B pharmacy |
| Payment underwriting | High risk, manual | High risk, but certification pathways exist |
| Margin structure | Product margin, yours entirely | Shared with platform, prescriber and pharmacy |
| Who owns the customer | You | Usually shared |
When prescribed telehealth is genuinely the better answer
We would rather say this plainly than have you discover it after signing with us.
- You want to make claims. If the business only works when you can describe outcomes, the research lane will never fit and trying to force it is how operators get shut down.
- Your audience is consumers. An influencer audience of individuals is a patient population, not a research buyer base.
- You want payment stability above margin. Certification pathways in the prescribed lane are expensive and slow, but they end the processor problem.
- You have no appetite for the compliance discipline. Holding research positioning across every page, every reply and every partnership is ongoing work.
When research supply is the better answer
- You are selling to businesses, not individuals
- You want the whole margin and the whole customer relationship
- You want your own brand on the product, not your brand on someone else’s clinic
- You can hold the claim line without resenting it
The hybrid question
Operators frequently ask whether they can run both. The honest answer is that a human-use consumer
brand and a research supply brand should not share a name, a domain, or a marketing pixel. The
firewall is the point. Two lanes, two identities, or one lane done properly.
What we will tell you on a call
If your model needs claims, needs consumers, or needs a prescriber, we will say so and we will not try to sell you supply. That conversation costs us an account and saves you a year.